This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James G. Chandler, MD

Arch Surg. 1993;128(8):925-940.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The history of the surgical treatment of portal hypertension is pockmarked by abbreviated observation of a small series² and sometimes resounding pessimism,^3,4 but sporadic success with a myriad of techniques,¹ refurbishment of once-abandoned procedures,^5,6 and occasional innovation^7,8 have kept it going forward. Perhaps intrahepatic portosystemic endovascular stents introduced percutaneously through the internal jugular vein will remain patent and become widely used. The technique is minimally invasive, and so far results in eight patients have been quite encouraging.⁸

According to Whipple,⁵ normal portal pressure varies from 8 to 13 mm Hg. Portal hypertension, defined as chronic elevation above this level, is caused in some instances by extrahepatic thrombosis, but more commonly by intrahepatic presinusoidal or postsinusoidal obstruction. The simple causal relationship of increased pressure brought about by increased resistance is immediately confounded by manifold circulatory alterations focused at first in the splanchnic viscera, including . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Surgery, University of California, Davis—East Bay, Oakland and the Shiley Heart Valve Research Center, Irvine, Calif.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?